Pfizer Inc.
RSV F Protein Mutants
Last updated:
Abstract:
The present disclosure relates to RSV F protein mutants, nucleic acids or vectors encoding a RSV F protein mutant, compositions comprising a RSV F protein mutant or nucleic acid, and uses of the RSV F protein mutants, nucleic acids or vectors, and compositions.
Status:
Application
Type:
Utility
Filling date:
1 Oct 2020
Issue date:
28 Jan 2021